A carregar...
Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
BACKGROUND: Metastatic melanoma is a highly chemotherapy resistant tumour. The use of newer targeted therapies alone and in combination with chemotherapy may offer new hope of improving response to treatment. Dasatinib, a multi-target kinase inhibitor, is currently approved for the treatment of chro...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2569026/ https://ncbi.nlm.nih.gov/pubmed/18823558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-53 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|